Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559234 · ClinicalTrials.gov registry record
Potential Research Participants for Future Studies of Inherited Eye Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 400
- Enrollment target
NCT00559234 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 400 participants.
The verdict
NCT00559234 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This study will evaluate potential candidates for future clinical research studies related to diagnosed or undiagnosed genetic eye disorders or diseases. It will not test any new treatments, but it may arrange for standard treatments for existing eye disorders. The purpose of the study is to train eye doctors and medical researchers at the National Institutes of Health in appropriate methods and procedures for treating patients with genetic eye diseases, and to expand the pool of possible participants for future research studies and trials on eye health. Volunteers for this study may be adults and minor children who have been diagnosed with or are at risk for having a genetic eye disease. Candidates may not have any other medical conditions that would interfere with the researchers' ability to perform the examinations and procedures required for this study. Participants will give a complete medical and family history and undergo a series of tests and procedures as part of this research study. The procedures include a full eye examination and vision testing, electrooculography and an electroretinogram to examine the function of the retina, and flourescein angiography to provide information on the flow of blood in the participant's eyes. Participants will provide research material for further studies by giving a blood sample to be held for genetic testing and analysis, and adult participants will also undergo a skin biopsy to provide cell tissue for additional research material. At each clinic visit, participants will receive treatment for their genetic eye disease as needed, including medications or surgical procedures. Participants may remain a part of this study for up to three years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-11-09 |
| Est. Completion | 2008-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00559234
The ClinicalTrials.gov registry entry for NCT00559234 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00559234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00559234 about?
NCT00559234 is a clinical study titled "Potential Research Participants for Future Studies of Inherited Eye Diseases". This study will evaluate potential candidates for future clinical research studies related to diagnosed or undiagnosed genetic eye disorders or diseases. It will not test any new treatments, but it may arrange for standard treatments for existing eye disorders. The purpose of the study is to train e...
What is the current status of trial NCT00559234?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-11-09. Estimated completion is 2008-10-03.
Who is sponsoring clinical trial NCT00559234?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.